PERTH, AUSTRALIA and SAN GWANN, MALTA / ACCESSWIRE / June 20, 2019 / Neurotech International Limited (ASX: NTI) (“Neurotech” or “the Company”) has announced that it has launched a pilot version of Mente Clinic, a virtual clinic that enables clinicians to interact with their Mente patients and remotely monitor their progress.

Accessed via www.menteclinic.com, appointments can be set up with clients via video conferencing, and usage is monitored remotely. Its goal is to enable clinicians to extend their practice, provide a service to clients in areas where access to a clinic is restricted, and monitor Mente clients’ progress.

Neurotech has launched its Early Adopter Program in all geographic regions where the Mente can be used. Early Adopters will benefit from substantial discounts on Mente’s Starter Pack and subscription model. There are no contractual obligations, but Neurotech will encourage early adopters to provide ongoing feedback on usability and the progress registered by users.

CLINIC IS OPEN TO PARENTS

Parents also have the option to join the Early Adopter Program, and through a simple process, they can book consultations with a Mente specialist or order a starter pack comprising a bundle of therapy sessions and the Mente headband.

MENTE IOS NOW AVAILABLE

The public release version of the Mente iOS application is now available on the App Store. Mente clients can now choose between the iOS or Android versions of the app.

Peter Griffiths, CEO and Managing Director, said, “Following the launch of the subscription model in March, we are very excited about Mente Clinic and our Early Adopters Program. We want our Early Adopters to play a leading role as we work to expand the reach of Mente. Through their participation in this program, they can benefit from introductory pricing and help us by providing ongoing feedback on Mente and its benefits.”

-ends

About Neurotech

Neurotech International Limited is a medical device and solutions company incorporated in Australia and operating through its wholly owned, Malta-based subsidiary AAT Research Limited. Neurotech’s primary mission is to improve the lives of people with neurological conditions, with in-home use and clinical neurotechnology solutions that are both accessible and affordable. Through flagship device Mente and its associated platform, Neurotech is focused on facilitating the development and commercialization of technological solutions for the screening and treatment of symptoms associated with conditions such as autism. Mente is the world’s first home therapy that is clinically proven to increase engagement and improve relaxation in autistic children with elevated Delta band brain activity.

For more information about Neurotech and Mente Autism please visit: http://www.neurotechinternational.com. http://www.mentetech.com. http://www.menteclinic.com.

Media inquiries

Press@mentetech.com

SOURCE: Neurotech International Ltd

ReleaseID: 549239

ATLANTA, GA / ACCESSWIRE / June 20, 2019 / Findit, Inc. (OTC PINK: FDIT) a Nevada Corporation provides individuals a place to create the content they want indexed in search engines. While individuals are often focused on their social media pictures that they post on Facebook, Instagram and Pinterest and share their thoughts on Twitter, the people that these posts reach are limited to your friends and followers and are not indexed in Google, Yahoo and Bing. There can be value to posting on these social platforms depending on your objective when you take the time to create a post. What do you want to achieve with that post?

For so many young people who are creating their life canvases’ online, what is the painting that others are going to see when they look at these paintings now and in years to come? While many people brush and laugh off the content they are posting, others like it or not are judging it. Colleges and Universities along with employers judge the content they see of a candidate when they are applying for enrollment or employment. The fact is, what you post does matter which means your objective in the content you are posting matters as well.

Findit gives you a central place to create content that you want seen, shared, and indexed from one social networking portal.

From Findit, you can:

manage the content you want to post
control the content you want Google, Yahoo, Bing and Findit to index
share your content, which others can also do when they see it.

The power of posting in Findit with the objective of ‘this is the content I want people to see when they Google me’, often becomes the outcome.

https://www.youtube.com/watch?v=WIfJX6ZyMCk

Here Is How It Works

Individuals create a free account on Findit. Once they create their account, they can input a screen name. The screen name is able to be seen by everyone and crawled by outside search engines and be indexed in these search engines. By entering your full name as your screen name this gives search engines a clear and exact match of who the Findit account belongs to and how relevant they should deem this search result.

In addition to the screen name, Findit offers all members a Findit address. The address is an extension that comes after Findit.com. Findit also recommends the Findit URL address be your name as well. The addresses are offered at $7.95 each, annually. The recommendation is to get one address with your full name with no spaces and one with hyphens between each name of your full name. If you and someone else share the same name, you can add a city that you live in or town or state. This addition is a really nice add on to the address so that Google and other search engines have additional ways to identify you in search results.

Once you have completed the screen name and decided what you want your Findit address to be (optional) you can begin to upload the content you want people to see when they search your name.

Findit provides an area for pictures, a place to upload articles, a place to upload audio files that can include podcasts, and the Right Now section which is a very strong online marketing tool where individuals can post content that they want people to find on the web when they search their name. Each Right Now post can include photos, a video link from Youtube, Vimeo, or a 10 second video shot through the Findit App, a link, an article, and can be back-dated, published immediately, or scheduled into the future.

All posts, once created from the Findit App or from the website, can be shared to Instagram, Facebook or Twitter along with being able to send as an email, text or through WhatsApp.

Many people, young or old, may not have negative search results indexing in Google, Yahoo and Bing yet and maybe they never will. However, it is often critical to get in front of what could possibly happen later in life by taking control of the content now and post what you want indexed and prioritized in search engines. You do this now so if and when an unfortunate occurrence does happen, your web footprint already has hundreds if not more results, that you created about yourself, indexing at the top of search results, making it more difficult for the negative one(s) to penetrate. Others that do have search results that they wished were not indexing at the top can and ought to use Findit to provide a solution to building your own online footprint, the one you want people to see.

Findit, in addition to offering a plethora of tools to assist anyone looking to increase their online web presence provides online marketing and branding services to customers that include but are not limited to individuals, general contractors, roofers, pool builders, jewelry distributors and CBD companies.

Clark St. Amant of Findit stated, “I recently took a 3 week trip through Asia and the simplicity of posting through my Findit account from the App and having the option of sharing directly from the Findit App to my Facebook and Twitter account was extremely convenient and made things much easier to reach all of my friends and followers while also getting all of my pictures and posts indexing in Google. By posting to Findit first and then sharing to the other platforms including Twitter it simplifies things and eliminates having to do a similar post 4 different times. It is the future of social now.”

Download the Findit Inc App in Google Play Store

https://play.google.com/store/apps/details?id=quickapp.findit.app

Download the Findit Right Now App in Apple App Store

https://apps.apple.com/us/app/findit-right-now-app/id1458638908?ls=1

About Findit, Inc.

Findit, Inc., owns Findit.com a Social Media Content Management Platform that provides an interactive search engine for all content posted in Findit to appear in Findit search. The site is an open platform that provides access to Google, Yahoo, Bing, and other search engines crawl content posted in Findit so it can be indexed in these search engines as well. Findit provides Members the ability to post, share and manage their content. Once they have posted in Findit, we ensure the content gets indexed in Findit Search results. Findit provides an option for anyone to submit URLs that they want indexed in Findit search result, along with posting status updates through Findit Right Now. Status Updates posted in Findit can be crawled by outside search engines which can result in additional organic indexing. All posts on Findit can be shared to other social and bookmarking sites that include but are not limited to Facebook, Twitter, LinkedIN and Pinterest by members and non-members. Findit provides Real Estate Agents the ability to create their own Findit Site where they can pull in their listing and others through their IDX account and post listings manually. Findit, Inc., is focused on the development of monetized Internet-based web products that can provide an increased brand awareness of our members. Findit, Inc., trades under the stock symbol FDIT on the OTC Pinksheets.

Safe Harbor:

This press release contains forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the ‘Exchange Act’), including statements regarding potential sales, the success of the company’s business, as well as statements that include the word believe or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Findit, Inc. to differ materially from those implied or expressed by such forward-looking statements. This press release speaks as of the date first set forth above, and Findit, Inc. assumes no responsibility to update the information included herein for events occurring after the date hereof. Actual results could differ materially from those anticipated due to factors such as the lack of capital, timely development of products, inability to deliver products when ordered, inability of potential customers to pay for ordered products, and political and economic risks inherent in international trade.

Contact:

Peter Tosto
404-443-3224

SOURCE: Findit, Inc.

ReleaseID: 549396

ATLANTA, GA / ACCESSWIRE / June 20, 2019 / Aureus, Inc. (OTC PINK: ARSN), www.AureusNOW.com, a food brand development company that exclusively operates the online sales of Yuengling’s Ice Cream brand, as well as select Yuengling retail distribution, is thrilled to announce it has completed the acquisition of Yuengling’s Ice Cream (“Yuengling’s”). As indicted in an earlier press release, the Company executed a revised LOI to acquire 100% of the assets of Yuengling’s, instead of a stock purchase.

The asset purchase is structured as an Article 9 asset sale between Aureus and Yuengling’s senior lender, Mid Penn Bank. A direct result of this structure is the elimination of approximately $3 million in Yuengling’s liabilities, greatly improving the balance sheet of the combined Company.

“By reducing our liabilities and having access to capital through the public markets, the closing of the deal with Aureus provides a great platform to move Yuengling’s Ice Cream forward”, said Rob Bohorad, Yuengling’s CFO.

“Now that the acquisition is complete, we can really focus our efforts on new product development and new business development”, commented Everett Dickson, Aureus’ President.

David Yuengling, Yuengling’s President, added, “the acquisition does not really change anything on a daily basis, though. We will still focus on making the highest quality products and providing the best experience for our customers. Now, we simply have more resources to do better things with the company.”

About Aureus, Inc.

Management and ownership recently changed hands. The new focus is on acquiring specific assets in and related to the food industry, with a focus on ice cream. Aureus holds certain exclusive marketing rights to the Yuengling Ice Cream brand, and additional acquisition rights for further business elements of the brand. The goal of Aureus in the operation of these rights is to consolidate all factors that are positive for the Yuengling brand into a synergistic success for Aureus shareholders as well as the next generation of Yuengling consumers.

About Yuengling’s Ice Cream

Developed by American businessman Frank D. Yuengling, as a dairy business to help support the Yuengling family brewery during the 1920s Prohibition period, Yuengling’s Ice Cream has a strong tradition of making exceptional gourmet ice cream products in central Pennsylvania. The fan-favorite brand continues advancing its legacy and its renowned dairy quality, by using locally sourced dairy ingredients that contain no added hormones.

David Yuengling and Rob Bohorad revived the brand in 2014 and an American classic was re-born. In 2018, positioned for the brands next stage of development, Yuengling’s Ice Cream forged a partnership with YIC – Online Distributors, to distribute the iconic ice cream brand online, now via Aureus. Today, Yuengling’s Ice Cream is delivered directly to the doorsteps of its consumers across the nation.

The Yuengling’s Ice Cream Corporation- as it has been since 1935- is stand alone, and separately owned and run companies from D. G. Yuengling and Sons, Inc Brewery.

Safe Harbor Statement

This communication contains statements that may constitute “forward-looking statements” within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of US Highland, Inc and members of its management as well as the assumptions on which such statements are based.

Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully, and the ability to complete before-mentioned transactions.

The Company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

For More Information

Contact & Media Inquiries:

Aureus.now@gmail.com
404.885.6045
www.AureusNow.com
Twitter: www.twitter.com/AureusNow

SOURCE: Aureus, Inc.

ReleaseID: 549393

VANCOUVER, BC / ACCESSWIRE / June 20, 2019 / LED Medical Diagnostics Inc. (“LED” or the “Company”) (TSXV: LMD) is pleased to announce that Mr. George Reznik and Dr. Lou Shuman were appointed to the Company’s board of directors during LED’s Annual General Meeting, held on June 19, 2019 in Vancouver, BC. George Reznik will also be serving as the Chair of the Audit Committee.

George Reznik is the Chief Financial Officer (“CFO”) and Corporate Secretary of Intrinsyc Technologies Corporation. Mr. Reznik has more than twenty-five years of experience in executive finance and operations roles with the last twenty years spent at rapidly growing public companies in the high technology industry. He has extensive expertise in international corporate finance, strategic business planning, mergers and acquisitions, business restructuring and growth management, investor relations, and operational management in addition to public company reporting. Prior to joining Intrinsyc, Mr. Reznik was CFO of DDS Wireless in which he was instrumental in execution of a high growth strategic acquisition strategy that doubled revenues with strong profitability in addition to having formerly been the CFO and Chief Operating Officer of Infowave Software, and the Vice President of Finance at Pivotal Corporation where he played a leadership role through its IPO on Nasdaq and its subsequent rapid business growth. Mr. Reznik previously was the Corporate Finance Valuation Practice Leader of Deloitte and was with the firm for over twelve years primarily based in Canada and the UK. Mr. Reznik is a Chartered Professional Accountant – Chartered Accountant (CPA, CA), a Chartered Business Valuator (CBV), a Certified Fraud Examiner (CFE) and holds a Bachelor of Commerce (Honors) degree from the University of Manitoba. He is the Chair of the BC Tech Association CFO Council and was the recipient of the BC Public Company CFO of the Year award in 2017.

Lou Shuman, DMD, CAGS, is the president and CEO of Cellerant Consulting Group, dentistry’s leading incubator and accelerator. Cellerant services clients that range from venture-funded startups, Fortune 500 dental industry companies, and dental industry associations (such as the ADA). Dr. Shuman is a graduate of Boston University School of Dental Medicine with a specialty in orthodontics. He is a recognized key opinion leader in the fields of dental technology and digital marketing and holds clinical advisory and editorial positions with the dental industry’s leading publications, including Dentistry Today, Dental Economics, Inside Dentistry, Dental Products Report, Orthodontic Practice US, Seattle Sleep Education LLC, and Dental Sleep Practice. He authors national columns for Dental Products Report and Dental Economics and is on the boards of the Foundation for Airway Health and the Dental Assisting National Board. Prior to starting Cellerant, Dr. Shuman was president of Pride Institute and Vice President of Clinical Education and Strategic Relations at Align Technology. He is also the co-founder of a new venture-funded technology company, LightForce Orthodontics.

“I am excited to welcome two new members to our board of directors,” stated Dr. David Gane, CEO of LED. “Dr. Shuman brings independent dental domain business experience, strategic thinking and many valuable relationships in the dental profession to our board, while Mr. Reznik will contribute his many years of experience in corporate finance, corporate governance and business leadership. Both Dr. Shuman and Mr. Reznik are uniquely talented individuals to help guide us forward in our business growth.”

LED also announces that James Topham did not stand for reappointment as a director at the Annual General Meeting. “We would like to thank James for his service and contributions to LED,” concluded Dr. Gane.

About LED Medical Diagnostics

LED Medical Diagnostics Inc. is a dental imaging technology provider focused on delivering state-of-the-art imaging software and systems. Through its wholly-owned subsidiaries LED Dental Inc., LED Dental Ltd., and Apteryx, Inc., LED Medical has provided dentists and oral health specialists with advanced diagnostic imaging products and software for over 20 years. LED’s proprietary technologies include the VELscope Vx Enhanced Oral Assessment and TUXEDO Intraoral Sensors, in addition to Apteryx’s XrayVision, XVWeb and XrayVision DCV imaging software solutions.

Backed by an experienced leadership team and dedicated to a higher level of service and support, LED is committed to providing dental practitioners with the best technology available by identifying and adding leading products to its growing portfolio. The Company is currently listed on the TSXV under the symbol LMD, the OTCQB under the symbol LEDIF, as well as the Frankfurt Stock Exchange under the symbol LME.

Media Contact:

LED Dental
Chris Koch
Phone: 678.293.9413
Email: chris.koch@leddental.com

Corporate
Contact:

LED Medical
David Gane, CEO
Phone: 604.434.4614 ext 227
Email:
david.gane@leddental.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: LED Medical Diagnostics Inc.

ReleaseID: 549391

TORONTO, ON / ACCESSWIRE / June 20, 2019 / GeneNews Limited (“GeneNews” or the “Company”) (TSX: GEN) is pleased to report that shareholders voted in favour of all items of business, including the election of all nominee directors listed in the Company’s management information circular dated May 15, 2019 (the “Circular”), at its annual and special meeting of shareholders held on June 19, 2019 (the “Meeting”).

The results of the vote for the election of directors are set out below:

Nominee

Votes For

Votes Withheld

James Howard-Tripp

96.86%

3.14%

Rory Riggs

99.84%

0.16%

Garth MacRae

99.85%

0.15%

Harry Glorikian

99.80%

0.20%

Thomas D. Stewart, Jr.

99.78%

0.22%

GeneNews further announces that shareholders representing approximately 99.93% of votes cast at the Meeting, by proxy or in person, approved a special resolution authorizing the Company to amend its articles to change its name to “StageZero Life Sciences, Ltd.” (the “Name Change”). The effective date of the Name Change will be the date of issuance of a Certificate of Amendment by the Director under the Business Corporations Act (Ontario) upon filing by the Company of Articles of Amendment. The Company intends to file Articles of Amendment for the Name Change later today.

“The name change to StageZero Life Sciences reflects the Company’s dedication to finding cancer as well as multiple diseases in the earliest possible stages (Stage 0) through whole blood,” says James R. Howard-Tripp, Chairman and CEO of GeneNews. “While our focus remains on commercializing advanced diagnostics for early cancer detection, our primary mission is to finalize the validation of our next generation test, Aristotle™, a blood test for simultaneously screening for ten specific cancers from a single sample of blood. We will also explore the application of Aristotle to multiple disease states in Neurology, Gastroenterology, Cardiology, and Autoimmune Disorders.”

In addition to the election of directors and the Name Change, shareholders voted in favour of the following matters:

Appointment of BDO Canada LLP as auditors of the Company;
Renewal of the Company’s stock option plan;
Approval of the Company’s upcoming Unit Financing; and
Approval of a consolidation of the Company’s common shares

More specific details of the matters approved at the Meeting are set forth in the Circular and posted on the System for Electronic Data Analysis and Retrieval (SEDAR) at www.sedar.com. Voting results are released in accordance with Toronto Stock Exchange (“TSX”) requirements. Detailed voting results for the Meeting are also available on SEDAR.

The new website for the Company will be www.StageZeroLifeSciences.com. This name change will also apply to the Company’ U.S. Lab, Innovative Diagnostic Laboratory.

In addition to the Name Change, the Company will change its ticker symbol on the TSX to “SZLS”. The intended date for the activation of the new ticker is on or about June 26, 2019. Until then, the Company’s stock will continue to trade under the existing “GEN ” ticker symbol.

About the Company

The Company is dedicated to the early detection of cancer and multiple disease states through whole blood. Our next generation test, Aristotle®, is a multi-cancer panel for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle is built on our proven and proprietary Sentinel Principle Technology Platform, which was validated on 10,000 patients and used to develop the first liquid biopsy for Colorectal Cancer. Further validation of the Aristotle test is currently underway. In addition to building a pipeline of products for early cancer detection, the Company operates a CAP accredited and CLIA certified reference laboratory based in Richmond, Virginia that offers the ColonSentry® test as well as licensed biomarker tests for lung, breast and prostate cancers. To learn more visit www.stagezerolifesciences.com.

Forward-Looking-Statements

This press release contains forward-looking statements identified by words such as “expects,” “will,” “anticipates,” “plans,” “believes,” “considers,” “intends” and other similar expressions, which reflect the Company’s current expectations regarding future events. The forward-looking statements involve risks and uncertainties that could cause the Company’s actual events to differ materially from those projected herein. Investors should consult the Company’s ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements, except as required by law.

Company Contact:

James R. Howard-Tripp
Chairman & CEO
jhoward-tripp@genenews.com
Tel. (905) 209-2030

Jerome Cliche
Financial Communication Advisor
jcliche@genenews.com
Tel. (514) 815-8799

SOURCE: GeneNews Limited

ReleaseID: 549390

TEL AVIV, ISRAEL / ACCESSWIRE / June 20, 2019 / FIRST BITCOIN CAPITAL CORP (OTC PINK: BITCF) (“the Company”) is pleased to announce that it has released its financial results for 2018.

For the year ending 2018 First Bitcoin’s assets increased from US$1,279,832 to $1,955,062. Also in 2018 income and asset gains were mostly a result of increases in consulting revenues together with receiving a convertible note with a face value of $1,000,000 in exchange for the Company’s mineable cryptocurrency “BIT” which can be followed via coinmarketcap.com.

When the audit is completed, expected within 2-3 weeks, we do not anticipate these results to differ but can give no assurances that the company’s auditors will arrive at the same numbers.

First Bitcoin has endeavored to complete a third year of audited financial statements with the intention to list on the CSE and resume trading on a higher market in the USA as soon as our PCAOB auditor completes their 2018 audit of First Bitcoin’s financial results.

Our financial statements can be viewed here:

https://firstbitcoin.io/investors/

FACEBOOK’s LIBRA coin discussion:

Facebook Inc. announced Tuesday it will roll out its highly anticipated digital crypto currency in 2020, intended to be used to make payments worldwide over the web as well as on its social-media platform.

https://newsroom.fb.com/news/2019/06/coming-in-2020-calibra/

Wall Street Journal published recently: “What is Libra? Libra is a new cryptocurrency-a digital currency that uses cryptography, a method of protecting information, to verify transactions-that Facebook will launch next year. People who use Facebook’s Messenger service, WhatsApp, or who download a stand-alone app will be able to access it through a digital wallet. It is an alternative to bitcoin that is powered by blockchain. However, Facebook hopes it will be used by a much wider base.

https://www.wsj.com/articles/libra-coin-what-you-need-to-know-about-facebooks-answer-to-bitcoin-11560864351

Blockchain is a type of digital ledger that is distributed across a large network of computers, run by powerful mathematical computations. It is like a giant spreadsheet that is shared widely. Every time someone updates the spreadsheet, for instance by logging a financial transaction, every other user can see the change. That theoretically provides transparency and prevents any single central source from controlling the flow of information-or money.

So Libra is like bitcoin?

Yes and no. Both are essentially digital versions of cash designed to allow users to directly exchange value online, but there are major differences.

Facebook is looking to build a payments network by creating an online ecosystem on which users can buy things and pay each other. Bitcoin was conceived as a payment mechanism, but its network has had trouble processing a large number of transactions quickly. Instead, bitcoin has evolved into a kind of digital gold used to store value rather than exchange it.

Why is Facebook getting into this?

Facebook says its currency will make it possible to provide basic financial services to millions of people around the world who don’t have a bank account, or who can’t afford to send money overseas. It could help small businesses that can’t get access to credit, too.

The Company signed up as a member of growing Libra online community and will evaluate this new blockchain technology and potential applications and integrations with Company’s existing projects.

About First Bitcoin Capital Corp

First Bitcoin Capital Corp (OTCMARKETS:BITCF) (NASDAQOTH: BITCF) (CRYPTO:BITCF) began developing digital currencies, proprietary Blockchain technologies, and the digital currency exchange – www.CoinQX.com (in Beta) in early 2014. We saw this step as a tremendous opportunity to create further shareholder value by leveraging management’s experience in developing and managing complex Blockchain technologies and in developing new types of digital assets. Being the first publicly-traded cryptocurrency and BlockChain-centered Company, we provide our shareholders with diversified exposure to digital cryptocurrencies and BlockChain technologies.

The Company began developing it’s own blockchain and cryptocurrency called First Bitcoin (COIN:BIT) in 2016. Recently the Company updated the BIT wallet and added more functionality. Users are able to generate BIT through the processes of POW and POS mining. The First Bitcoin cryptocurrency has a current supply of 20,707,629,255 BIT. It is currently trading on LIVECOIN.net

https://coinmarketcap.com/currencies/first-bitcoin/

Contact us via: info@firstbitcoin.io or visit www.firstbitcoin.io

Forward-Looking Statements

Certain statements contained in this press release may constitute “forward-looking statements.” Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as may be disclosed in company’s filings. In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, and governmental and public policy changes. The forward-looking statements included in this press release represent the Company’s views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of the press release. Such forward-looking statements are risks that are detailed in the Company’s website and filings.

SOURCE: First Bitcoin Capital Corp.

ReleaseID: 549379